Every AI newsletter,Tianfeng Securities issued a research report on August 13, stating that WuXi AppTec (603259.SH, latest price: 138.74 yuan) buy rating is maintained. The main reasons for the rating include: 1) CDMO continues to broaden its service radius and open up space for performance; 2) CGTCTDMO accumulates energy and enhances business development flexibility; 3) continues to empower the research and development of new drugs, and the “long-tail customer” strategy is further strengthened. Risk warning: The number of orders and growth are less than expected, the release of production capacity is less than expected, the impact of exchange rate fluctuations on performance, the risk of investment income fluctuations, and the risk of core personnel loss.
AI comment: WuXi AppTec has received 20 securities research reports in the past month, buying 19 companies, with an average target price of 192.82 yuan, which is 54.08 yuan higher than the latest price of 138.74 yuan, and the target average price has increased by 38.98%.
Every Jing Toutiao (nbdtoutiao)——With 80,000 undocumented institutions and 100,000 undocumented personnel, public hospitals have been squeezed out, how long can the story of the high growth of the medical aesthetics industry be told?
(Reporter Wang Xiaobo)
Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. According to this operation, at your own risk.
Copyright Notice
1This article is the original work of “Daily Economic News”.
2
Without the authorization of “Daily Economic News”, it may not be used in any way, including but not limited to reprinting, extracting, copying or creating mirror images, etc., offenders must be investigated.
3Copyright cooperation telephone: 021-60900099.